Stocks and Investing
Stocks and Investing
Mon, August 22, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, August 19, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sarah James Maintained (AVAH) at Buy with Decreased Target to $5 on, Aug 19th, 2022
Sarah James of Barclays, Maintained "Aveanna Healthcare Holdings Inc." (AVAH) at Buy with Decreased Target from $7 to $5 on, Aug 19th, 2022.
Sarah has made no other calls on AVAH in the last 4 months.
There are 4 other peers that have a rating on AVAH. Out of the 4 peers that are also analyzing AVAH, 3 agree with Sarah's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Tanquilut of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $2.5 on, Friday, July 22nd, 2022
- David Macdonald of "Truist Securities" Downgraded from Strong Buy to Hold on, Tuesday, July 5th, 2022
- Scott Fidel of "Stephens & Co." Downgraded from Buy to Hold and Decreased Target to $3.5 on, Tuesday, June 21st, 2022
This is the rating of the analyst that currently disagrees with Sarah
- John Ransom of "Raymond James" Maintained at Strong Buy with Decreased Target to $6 on, Monday, August 15th, 2022
Contributing Sources